Newsroom
Keep up with the latest news, press releases, and highlights from NightWare, Inc..
Company logo
About
NightWare, Inc. is a Minneapolis-based digital health company and developer of the only FDA-cleared prescription digital therapeutic indicated for nightmare disorder in adults with post-traumatic stress disorder (PTSD). The NightWare system pairs an Apple Watch with a proprietary AI application to monitor sleep physiology and deliver personalized, non-awakening vibrotactile interventions that disrupt the nightmare cycle. NightWare holds De Novo 510(k) FDA clearance and Breakthrough Device Designation. The company serves patients across VA health system, commercial, and direct-pay channels and is currently executing a national VA Pathfinder Innovation Pilot. NightWare is a prescription device. It is not a standalone therapy for PTSD and should be used in conjunction with clinician-directed care. Individual results may vary. www.nightware.com
Contact
Press Contact:
Matt Tucker
NightWare, Inc.
8900 Excelsior Blvd
Hopkins, MN 55343
Contact email:
matthew@nightware.com
Website:
https://nightware.com/
